SCHEMBL1991935

SCHEMBL1991935

CCOC(=O)Cc1nc(Cl)nc2cccc(C)c12

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 2/20 0.44
ALDH1A1 P00352 6/20 0.41
KDM4E B2RXH2 4/20 0.41
KMT2A Q03164 3/20 0.41
MEN1 O00255 2/20 0.41
RXFP1 Q9HBX9 1/20 0.41
ELANE P08246 1/20 0.41
SMN1; SMN2 Q16637 3/20 0.40
MAPT P10636 1/20 0.39
HPGD P15428 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
RECQL P46063 1/20 0.39
RAB9A P51151 1/20 0.38
CHEK1 O14757 1/20 0.38
MAOB P27338 1/20 0.38
NLRP3 Q96P20 1/20 0.38
CYP1A2 P05177 1/20 0.38
PRNP P04156 1/20 0.38
HTT P42858 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31647297 0.81 ALDH1A1 (0.51) HSD17B10ALDH1A1KDM4EKMT2ARXFP1
SCHEMBL1991573 0.79 KDM4E (0.51) HSD17B10ALDH1A1KDM4EKMT2AMEN1
SCHEMBL1989725 0.78 ALDH1A1 (0.46) HSD17B10ALDH1A1KDM4EKMT2AMEN1
SCHEMBL2031142 0.77 HRH4 (0.54) ALDH1A1KMT2AMEN1ELANEMAPT
SCHEMBL6499160 0.74 HSD17B10 (0.44) HSD17B10ALDH1A1KDM4EKMT2AMEN1
SCHEMBL1993219 0.74 KDM4E (0.49) ALDH1A1KDM4EKMT2AMEN1SMN1; SMN2
SCHEMBL1990509 0.73 LATS1 (0.42) HSD17B10ALDH1A1KDM4ESMN1; SMN2RECQL
SCHEMBL1993736 0.72 ALDH1A1 (0.48) ALDH1A1KDM4EKMT2AMEN1SMN1; SMN2
SCHEMBL1997280 0.71 ELANE (0.44) ALDH1A1KDM4EELANETDP1
SCHEMBL29777989 0.71 ELANE (0.44) ALDH1A1KDM4EELANETDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110152243-A1 NOVEL THIENOPYRROLE COMPOUNDS ABBOTT LABORATORIES (US) 2011-06-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110152243-A1 NOVEL THIENOPYRROLE COMPOUNDS TPMT, TSLP, THPO HSD17B10 2995/4885ALDH1A1 297/4885KDM4E 3351/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.